Therapeutic Effect of Glycine Max (Soybean) Bioactive Components in Cvd and Obesity

Abstract

The cardiovascular diseases (CVD) and obesity are amongst the most prominent diseases across the globe. Hyperlipidemia is an underlying factor in the proliferation of these diseases. Food substances like soybean have been reported for its hypolipidemic property and decreased the risk of obesity and CVD by lowering the lipid concentration in serum profile.Many advanced researches explored that soya bean and soy related food products constitute a significant amount of bioactive components like oligosaccharides, globulin proteins (glycinin, beta-conglycinin), antioxidants, isoflavones (genistein, daidzen, glycitein), phytosterols (sitosterol, sitostanol ,campesterol) and phyto-estrogen. These components have eminent characteristics for the improvement of health that was seen in both humans and animals. After studying the results of different experimental researches, glycine max constituents and its supplements lowered cardiovascular parameters; lipid profile, triglycerides, and obesity level.